Annual Drug Patent Expiration for FYCOMPA
Fycompa is a drug marketed by Eisai Inc and is included in two NDAs. It is available from a single supplier. There are two patents protecting this drug and one Paragraph IV challenge.
FYCOMPA drug price trends.
This drug has ninety-three patent family members in thirty-three countries.
The generic ingredient in FYCOMPA is perpanel. One registered supplier for this compound. Additional details are available on the browser’s profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New Patent for the drug Eisai Inc FYCOMPA